0001127602-20-023248.txt : 20200810 0001127602-20-023248.hdr.sgml : 20200810 20200810161827 ACCESSION NUMBER: 0001127602-20-023248 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200807 FILED AS OF DATE: 20200810 DATE AS OF CHANGE: 20200810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith David Ross CENTRAL INDEX KEY: 0001650274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 201089616 MAIL ADDRESS: STREET 1: 251 BALLARDVALE STREET CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1226 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-08-07 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001650274 Smith David Ross 251 BALLARDVALE STREET WILMINGTON MA 01887 1 Corporate Executive VP & CFO Common Stock 2020-08-07 4 M 0 3304 144.67 A 24071 D Common Stock 2020-08-07 4 S 0 2297 216.4169 D 21774 D Common Stock 2020-08-07 4 S 0 1007 216.8165 D 20767 D Stock Options (Right to Buy) 144.67 2020-08-07 4 M 0 3304 0 D 2020-02-22 2024-02-22 Common Stock 3304 9914 D This transaction was executed in multiple trades at prices ranging from $215.72 to $216.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $216.72 to $216.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ David R. Smith 2020-08-10